{"transactions":[{"id":2483,"issuer":{"id":1805,"kind":"organization","name":"Sixth Street Lending Partners","symbol":"NONE"},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common shares of beneficial interest, par value $0.001","published_at":"2026-09-03T20:30:18.000Z","date":"2026-09-01","kind":"purchase","planned":false,"acquired":true,"shares":255924,"price":28.78,"value":7365492.72,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Sixth Street Lending Partners Advisers, LLC (\"Adviser\"). Adviser is managed by TSSP HoldCo Management, LLC (\"Holdco Management\"). Holdco Management is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of Holdco Management."}],"balance_after":2255597,"source":{"system":"sec-edgar","filing":"0001193125-26-381963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1925309/000119312526381963/ownership.xml","form_type":"4"}},{"id":2482,"issuer":{"id":1805,"kind":"organization","name":"Sixth Street Lending Partners","symbol":"NONE"},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common shares of beneficial interest, par value $0.001","published_at":"2026-09-03T20:30:18.000Z","date":"2026-09-01","kind":"purchase","planned":false,"acquired":true,"shares":1405583,"price":28.78,"value":40452678.74,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held directly by Sixth Street Lending Partners Note Issuer, LLC (\"Note Issuer\"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Reporting Person, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC."}],"balance_after":12560764,"source":{"system":"sec-edgar","filing":"0001193125-26-381963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1925309/000119312526381963/ownership.xml","form_type":"4"}},{"id":726660,"issuer":{"id":1805,"kind":"organization","name":"Sixth Street Lending Partners","symbol":"NONE"},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common shares of beneficial interest, par value $0.001","published_at":"2026-06-25T20:05:03.000Z","date":"2026-06-23","kind":"purchase","planned":false,"acquired":true,"shares":124477,"price":28.81,"value":3586182.37,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Sixth Street Lending Partners Advisers, LLC (\"Adviser\"). Adviser is managed by TSSP HoldCo Management, LLC (\"Holdco Management\"). Holdco Management is managed by a board of directors, which is currently comprised of Reporting Person. Reporting Person is the CEO of Holdco Management."}],"balance_after":1999673,"source":{"system":"sec-edgar","filing":"0001193125-26-282741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1925309/000119312526282741/ownership.xml","form_type":"4"}},{"id":726659,"issuer":{"id":1805,"kind":"organization","name":"Sixth Street Lending Partners","symbol":"NONE"},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common shares of beneficial interest, par value $0.001","published_at":"2026-06-25T20:05:03.000Z","date":"2026-06-23","kind":"purchase","planned":false,"acquired":true,"shares":683654,"price":28.81,"value":19696071.74,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held directly by Sixth Street Lending Partners Note Issuer, LLC (\"Note Issuer\"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Alan Waxman, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC."}],"balance_after":11155181,"source":{"system":"sec-edgar","filing":"0001193125-26-282741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1925309/000119312526282741/ownership.xml","form_type":"4"}},{"id":848639,"issuer":{"id":4591,"kind":"organization","name":"Sixth Street Specialty Lending, Inc."},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2026-03-11T20:20:53.000Z","date":"2026-03-10","kind":"purchase","planned":false,"acquired":true,"shares":45000,"price":18.47,"value":831150.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.27 to $18.57, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above."}],"balance_after":545000,"source":{"system":"sec-edgar","filing":"0001193125-26-102222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508655/000119312526102222/ownership.xml","form_type":"4"}},{"id":848638,"issuer":{"id":4591,"kind":"organization","name":"Sixth Street Specialty Lending, Inc."},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2026-03-11T20:20:53.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":18.18,"value":3636000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares of common stock, par value $0.01 per share (the \"Shares\") were purchased in multiple transactions at prices ranging from $17.865 to $18.445, inclusive. Mr. Waxman (\"Reporting Person\") undertakes to provide to Sixth Street Specialty Lending, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001193125-26-102222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508655/000119312526102222/ownership.xml","form_type":"4"}},{"id":853454,"issuer":{"id":4591,"kind":"organization","name":"Sixth Street Specialty Lending, Inc."},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2026-03-09T20:19:13.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":18.42,"value":3684000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $18.28 to $18.635, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001193125-26-098557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508655/000119312526098557/ownership.xml","form_type":"4"}},{"id":853453,"issuer":{"id":4591,"kind":"organization","name":"Sixth Street Specialty Lending, Inc."},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2026-03-09T20:19:13.000Z","date":"2026-03-05","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":18.46,"value":1846000.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares of common stock, par value $0.01 per share (the \"Shares\") were purchased in multiple transactions at prices ranging from $18.38 to $18.525, inclusive. Mr. Waxman (\"Reporting Person\") undertakes to provide to Sixth Street Specialty Lending, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth above."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001193125-26-098557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508655/000119312526098557/ownership.xml","form_type":"4"}},{"id":1104132,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"2020 Warrants","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":false,"shares":569991,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"expiration_date":"2027-04-02","underlying":"Common Stock","underlying_shares":90059},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104131,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"2020 Warrants","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":false,"shares":10829823,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"expiration_date":"2027-04-02","underlying":"Common Stock","underlying_shares":1711113},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104130,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"2018 Warrants","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":false,"shares":684731,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":118687},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104129,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"2018 Warrants","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":false,"shares":13009892,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"expiration_date":"2025-09-20","underlying":"Common Stock","underlying_shares":2255048},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104128,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series D Preferred Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":23574073,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings II, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10103175},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104127,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series D Preferred Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":1240740,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":531746},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104126,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series C Preferred Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":1915114,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":478779},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104125,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series C Preferred Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":13975155,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by TAO Barnett Investments LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3493789},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104124,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series C Preferred Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":15527951,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by TOP III Barnett Investments, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3881988},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104123,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Series C Preferred Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":6884058,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1721015},"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104122,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":true,"shares":90059,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"shares","element":"transactionShares","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":1219271,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104121,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":true,"shares":1711113,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"shares","element":"transactionShares","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The 2020 warrants were exercisable into Series C preferred stock at a price of $1.93 per share and into Common Stock at a price of $7.73 per share. Immediately prior to and in connection with the closing of the Issuer's IPO the 2020 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock.  The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":5687176,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104120,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":true,"shares":118687,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"shares","element":"transactionShares","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":1129212,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104119,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":true,"shares":2255048,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"shares","element":"transactionShares","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The 2018 warrants were exercisable at the option of the holder into shares of Series C Preferred Stock of the Issuer at an exercise price of $1.61 per share and into Common Stock at an exercise price of $6.44 per share. Immediately prior to and in connection with the closing of the Issuer's IPO, the 2018 warrants were exercised on a cashless basis into shares of Series C Preferred Stock which then automatically converted into Common Stock. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":3976063,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104118,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":10103175,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings II, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":10103175,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104117,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":531746,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series D Preferred Stock of the Issuer was convertible at the option of the holder into 0.25 shares of Common Stock of the Issuer and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's IPO. The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's Charter, in connection with the IPO. The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":1010525,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104116,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":478779,"ownership":{"direct":false,"nature":"Held by Sixth Street Specialty Lending, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"TSSP Holdco Management, LLC, a Delaware limited liability company (\"Holdco Management\"), manages Sixth Street Specialty Lending Advisers Holdings, LLC, a Delaware limited liability company (\"Adviser Holdings\"). The business and affairs of Sixth Street Specialty Lending Advisers, LLC, a Delaware limited liability company (\"Adviser\"), are managed by Adviser Holdings, the sole member of Adviser. Sixth Street Specialty Lending, Inc. is managed by Adviser."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":478779,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104115,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":3493789,"ownership":{"direct":false,"nature":"Held by TAO Barnett Investments LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":3493789,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104114,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":3881988,"ownership":{"direct":false,"nature":"Held by TOP III Barnett Investments, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":3881988,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1104113,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":78230,"kind":"organization","name":"TSSP Sub-Fund HoldCo LLC","position":1,"cik":"0001677508","reported_name":"TSSP Sub-Fund HoldCo LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-06-23T20:45:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":1721015,"ownership":{"direct":false,"nature":"Held by Barnett Equity Holdings, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Preferred Stock of Caris Life Sciences, Inc. (the \"Issuer\") was convertible at the option of the holder into 0.25 shares of common stock $.001 par value of the Issuer (the \"Common Stock\") and automatically converted into Common Stock immediately prior to and in connection with the closing of the Issuer's initial public offering (the \"IPO\"). The number of shares received upon conversion reflects certain adjustments pursuant to the terms of the Issuer's amended and restated certificate of formation (the \"Charter\"), in connection with the IPO. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"TSSP Sub-Fund Holdco, LLC, a Delaware limited liability company (\"Sub-Fund HoldCo\"), is the sole member of each of TAO SPV GP, LLC, a Delaware limited liability company (\"TAO SPV\"), and Empire SPV GP, LLC, a Delaware limited liability company (\"Empire SPV\"). TAO SPV is the managing member of each of (i) Barnett Equity Holdings, LLC; (ii) Barnett Equity Holdings II LLC; and (iii) TAO Barnett Investments LLC. Empire SPV is the managing member of TOP III Barnett Investments, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Sub-Fund HoldCo is managed by its sole member, whose managing member is Alan Waxman (\"Mr. Waxman\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO of Holdco Management. Each Reporting Person disclaims beneficial ownership over the reported securities herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of its or his pecuniary interest therein."}],"balance_after":1721015,"source":{"system":"sec-edgar","filing":"0000950170-25-089040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000095017025089040/ownership.xml","form_type":"4"}},{"id":1325569,"issuer":{"id":1805,"kind":"organization","name":"Sixth Street Lending Partners","symbol":"NONE"},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common shares of beneficial interest, par value $0.001","published_at":"2024-12-19T21:30:04.000Z","date":"2024-12-17","kind":"purchase","planned":false,"acquired":true,"shares":477048,"price":29.37,"value":14010899.76,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Sixth Street Lending Partners Advisers, LLC (\"Adviser\"). Adviser is managed by TSSP HoldCo Management, LLC (\"Holdco Management\"). Holdco Management is managed by a board of directors, which is currently comprised of Mr. Waxman. Mr. Waxman is the CEO and Managing Partner of Holdco Management."}],"balance_after":1875196,"source":{"system":"sec-edgar","filing":"0000950170-24-138484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1925309/000095017024138484/ownership.xml","form_type":"4"}},{"id":1325568,"issuer":{"id":1805,"kind":"organization","name":"Sixth Street Lending Partners","symbol":"NONE"},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common shares of beneficial interest, par value $0.001","published_at":"2024-12-19T21:30:04.000Z","date":"2024-12-17","kind":"purchase","planned":false,"acquired":true,"shares":2620037,"price":29.37,"value":76950486.69,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held directly by Sixth Street Lending Partners Note Issuer, LLC (\"Note Issuer\"). Note Issuer is controlled by its members, which are indirectly controlled by TAO Sutton Holdings, LLC. TAO Insurance Holdings, LLC is the managing member of TAO Sutton Holdings, LLC. A. Michael Muscolino is the managing member of TAO Insurance Holdings, LLC. Pursuant to the limited liability company agreement of TAO Insurance Holdings, LLC, Alan Waxman, as designated member of TAO Insurance Holdings, LLC has the authority to appoint the managing member of TAO Insurance Holdings, LLC."}],"balance_after":10471527,"source":{"system":"sec-edgar","filing":"0000950170-24-138484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1925309/000095017024138484/ownership.xml","form_type":"4"}},{"id":1779554,"issuer":{"id":746,"kind":"organization","name":"AvePoint, Inc.","symbol":"AVPT"},"owners":[{"id":87705,"kind":"organization","name":"Sixth Street Partners Management Company, L.P.","position":1,"cik":"0001812095","reported_name":"Sixth Street Partners Management Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2023-09-18T12:57:59.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":7777746,"price":6,"value":46666476.0,"ownership":{"direct":false,"nature":"Held by Avatar Investment Opportunities, LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the \"Milestones\"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 333,783 shares of Contingent Consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are owned directly by Avatar Investment Opportunities, LLC. Avatar Investment Opportunities, LLC's managing member is Redwood IV Finance 1, LLC, the managing member of which is Sixth Street Opportunities GenPar IV, L.P. (formerly known as TSSP Opportunities GenPar IV, L.P.). Sixth Street Opportunities GenPar IV, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":3756312,"source":{"system":"sec-edgar","filing":"0001387131-23-011233","document":"avpt-form4_091523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812095/000138713123011233/avpt-form4_091523.xml","form_type":"4"}},{"id":1779553,"issuer":{"id":746,"kind":"organization","name":"AvePoint, Inc.","symbol":"AVPT"},"owners":[{"id":87705,"kind":"organization","name":"Sixth Street Partners Management Company, L.P.","position":1,"cik":"0001812095","reported_name":"Sixth Street Partners Management Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2023-09-18T12:57:59.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":3904714,"price":6,"value":23428284.0,"ownership":{"direct":false,"nature":"Held by Avatar Investment Solutions 1, LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the \"Milestones\"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 167,571 shares of Contingent Consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are owned directly by Avatar Investment Solutions 1, LLC. Avatar Investment Solutions 1, LLC's managing member is TCS Finance 1, LLC, the manager of which is Sixth Street Growth GenPar, L.P. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":1885806,"source":{"system":"sec-edgar","filing":"0001387131-23-011233","document":"avpt-form4_091523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812095/000138713123011233/avpt-form4_091523.xml","form_type":"4"}},{"id":1779552,"issuer":{"id":746,"kind":"organization","name":"AvePoint, Inc.","symbol":"AVPT"},"owners":[{"id":87705,"kind":"organization","name":"Sixth Street Partners Management Company, L.P.","position":1,"cik":"0001812095","reported_name":"Sixth Street Partners Management Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2023-09-18T12:57:59.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":4984140,"price":6,"value":29904840.0,"ownership":{"direct":false,"nature":"Held by Avatar Investment Solutions (A), LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 213,895 shares of Common Stock that the Reporting Persons have the right to receive if the trading price of the Common Stock reaches certain thresholds (the \"Contingent Consideration\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the \"Milestones\"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Avatar Investment Solutions (A), LLC. Avatar Investment Solutions (A), LLC's managing member is TCS Finance (A), LLC, the managing member of which is Sixth Street Growth GenPar, L.P. (formerly known as TSSP Capital Solutions GenPar, L.P.), a Delaware limited partnership. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership (\"Management Company\"). Management Company is managed by its general partner, whose managing member is Alan Waxman."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":2407123,"source":{"system":"sec-edgar","filing":"0001387131-23-011233","document":"avpt-form4_091523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812095/000138713123011233/avpt-form4_091523.xml","form_type":"4"}},{"id":1855191,"issuer":{"id":746,"kind":"organization","name":"AvePoint, Inc.","symbol":"AVPT"},"owners":[{"id":87705,"kind":"organization","name":"Sixth Street Partners Management Company, L.P.","position":1,"cik":"0001812095","reported_name":"Sixth Street Partners Management Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T20:57:29.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":2100000,"price":6.16,"value":12936000.0,"ownership":{"direct":false,"nature":"Held by Avatar Investment Opportunities, LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the \"Milestones\"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 333,783 shares of Contingent Consideration, which were inadvertently reported as 332,552 shares in the Form 3 filed by the Reporting Persons on July 12, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are owned directly by Avatar Investment Opportunities, LLC. Avatar Investment Opportunities, LLC's managing member is Redwood IV Finance 1, LLC, the managing member of which is Sixth Street Opportunities GenPar IV, L.P. (formerly known as TSSP Opportunities GenPar IV, L.P.). Sixth Street Opportunities GenPar IV, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":11534058,"source":{"system":"sec-edgar","filing":"0001387131-23-007596","document":"avpt-form4_061323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812095/000138713123007596/avpt-form4_061323.xml","form_type":"4"}},{"id":1855190,"issuer":{"id":746,"kind":"organization","name":"AvePoint, Inc.","symbol":"AVPT"},"owners":[{"id":87705,"kind":"organization","name":"Sixth Street Partners Management Company, L.P.","position":1,"cik":"0001812095","reported_name":"Sixth Street Partners Management Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T20:57:29.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":1054277,"price":6.16,"value":6494346.32,"ownership":{"direct":false,"nature":"Held by Avatar Investment Solutions 1, LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the \"Milestones\"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 167,571 shares of Contingent Consideration, which were inadvertently reported as 166,953 shares in the Form 3 filed by the Reporting Persons on July 12, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are owned directly by Avatar Investment Solutions 1, LLC. Avatar Investment Solutions 1, LLC's managing member is TCS Finance 1, LLC, the manager of which is Sixth Street Growth GenPar, L.P. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Management Company. Management Company is managed by its general partner, whose managing member is Alan Waxman."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":5790520,"source":{"system":"sec-edgar","filing":"0001387131-23-007596","document":"avpt-form4_061323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812095/000138713123007596/avpt-form4_061323.xml","form_type":"4"}},{"id":1855189,"issuer":{"id":746,"kind":"organization","name":"AvePoint, Inc.","symbol":"AVPT"},"owners":[{"id":87705,"kind":"organization","name":"Sixth Street Partners Management Company, L.P.","position":1,"cik":"0001812095","reported_name":"Sixth Street Partners Management Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":1868,"kind":"person","name":"Waxman Alan","position":2,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T20:57:29.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":1345723,"price":6.16,"value":8289653.68,"ownership":{"direct":false,"nature":"Held by Avatar Investment Solutions (A), LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 213,895 shares of Common Stock that the Reporting Persons have the right to receive if the trading price of the Common Stock reaches certain thresholds (the \"Contingent Consideration\"), which were inadvertently reported as 213,106 shares in the Form 3 filed by the Reporting Persons on July 12, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Contingent Consideration vests in equal thirds if the trading price of Common Stock is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30-trading day period (the \"Milestones\"). If the Milestones are not met by the seventh anniversary of the closing of the issuer's initial public offering, then the unvested Contingent Consideration will be forfeited."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by Avatar Investment Solutions (A), LLC. Avatar Investment Solutions (A), LLC's managing member is TCS Finance (A), LLC, the managing member of which is Sixth Street Growth GenPar, L.P. (formerly known as TSSP Capital Solutions GenPar, L.P.), a Delaware limited partnership. Sixth Street Growth GenPar, L.P. is ultimately indirectly controlled by Sixth Street Partners Management Company, L.P., a Delaware limited partnership (\"Management Company\"). Management Company is managed by its general partner, whose managing member is Alan Waxman."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Management Company and Alan Waxman disclaim beneficial ownership over the reported securities, except to the extent of their pecuniary interest therein."}],"balance_after":7391263,"source":{"system":"sec-edgar","filing":"0001387131-23-007596","document":"avpt-form4_061323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812095/000138713123007596/avpt-form4_061323.xml","form_type":"4"}},{"id":4015283,"issuer":{"id":4591,"kind":"organization","name":"Sixth Street Specialty Lending, Inc."},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2018-03-05T21:13:23.000Z","date":"2018-03-01","kind":"purchase","acquired":true,"shares":1119.5,"price":18.28,"value":20464.46,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"TSL Advisers, LLC (\"TSL Advisers\") directly holds 2,732,307 shares (the \"TSL Shares\") of Common Stock of TPG Specialty Lending, Inc. (the \"Issuer\"), including 140,447.01 shares of Common Stock of the Issuer indirectly beneficially owned by Mr. Waxman (through his limited partnership interest in TSL Equity Partners, L.P., which is a member of TSL Advisers).  In addition, Mr. Waxman is a member of the board of directors of TSSP HoldCo Management, LLC, the managing member of TSL Advisers and therefore may be deemed to beneficially own all of the TSL Shares.  Mr. Waxman disclaims beneficial ownership of the TSL Shares except to the extent of his pecuniary interest therein."}],"balance_after":140447.01,"source":{"system":"sec-edgar","filing":"0000903423-18-000141","document":"waxman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508655/000090342318000141/waxman.xml","form_type":"4"}},{"id":4543136,"issuer":{"id":4591,"kind":"organization","name":"Sixth Street Specialty Lending, Inc."},"owners":[{"id":1868,"kind":"person","name":"Waxman Alan","position":1,"cik":"0001515132","reported_name":"Waxman Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President"}}],"security":"Common Stock","published_at":"2016-11-23T18:17:48.000Z","date":"2016-11-21","kind":"purchase","acquired":true,"shares":229.65,"price":18.39,"value":4223.2635,"ownership":{"direct":false,"nature":"See Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"TSL Advisers, LLC (\"TSL Advisers\") directly holds 2,732,307 shares (the \"TSL Shares\") of Common Stock of TPG Specialty Lending, Inc. (the \"Issuer\"), including 139,327.38 shares of Common Stock of the Issuer indirectly beneficially owned by Mr. Waxman (through his limited partnership interest in TSL Equity Partners, L.P., which is a member of TSL Advisers). In addition, Mr. Waxman is a member of the board of directors of TSSP HoldCo Management, LLC, the managing member of TSL Advisers and therefore may be deemed to beneficially own all of the TSL Shares. Mr. Waxman disclaims beneficial ownership of the TSL Shares except to the extent of his pecuniary interest therein."}],"balance_after":139327.38,"source":{"system":"sec-edgar","filing":"0000903423-16-001394","document":"waxman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508655/000090342316001394/waxman.xml","form_type":"4"}}]}